Cleared Traditional

Dewin Blastocyst Medium (with HSA and without HSA) (K231370) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231370 · Donnevie Medical Technology (Shanghai) Co. , Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
84d
Days
Class 2
Risk

K231370 is an FDA 510(k) clearance for the Dewin Blastocyst Medium (with HSA and without HSA). Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Donnevie Medical Technology (Shanghai) Co. , Ltd. (Shanghai, CN). The FDA issued a Cleared decision on August 4, 2023 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Donnevie Medical Technology (Shanghai) Co. , Ltd. devices

Submission Details

510(k) Number K231370 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 2023
Decision Date August 04, 2023
Days to Decision 84 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 160d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 50
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K231370.
SSS-NX (Serum Substitute Supplement-NX)
K233764 · Fujifilm Irvine Scientific · Apr 2024
V-PVP
K232125 · Vitromed GmbH · Mar 2024
G-Vitri™ Vitrification Freeze Media
K232942 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jan 2024
V-HYADASE
K222606 · Vitromed GmbH · May 2023
CryoX Vitrification Freeze Kit / Thaw Kit
K223265 · Zhejiang Horizon Medical Technology Co., Ltd. · May 2023
ARTSMedia In Vitro Culture Medium (AM-IVC Medium)
K220715 · Artsmedia Denmark Aps · Feb 2023